Diwakar R Pattabiraman

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Dna Methylation

Endoplasmic Reticulum Stress

Metastatic Breast Cancer

Top Venues

bioRxiv : the preprint server for biology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, W Todd Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics 16 (5) (2024)
Meisam Bagheri, Gadisti Aisha Mohamed, Mohammed Ashick, Mohamed Saleem, Nevena B Ognjenovic, Hanxu Lu, Fred W Kolling, Owen M Wilkins, Subhadeep Das, Ian S La Croix, Shivashankar H Nagaraj, Kristen E Muller, Scott A Gerber, Todd W Miller, Diwakar R Pattabiraman
Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. bioRxiv : the preprint server for biology (2023)
Meisam Bagheri, Min Kyung Lee, Kristen E Muller, Todd W Miller, Diwakar R Pattabiraman, Brock C Christensen
Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. bioRxiv : the preprint server for biology (2023)
Meisam Bagheri, Gadisti Aisha Mohamed, Mohammed Ashick, Mohamed Saleem, Nevena B Ognjenovic, Hanxu Lu, Fred W Kolling, Owen M Wilkins, Subhadeep Das, Ian S La Croix, Shivashankar H Nagaraj, Kristen E Muller, Scott A Gerber, Todd W Miller, Diwakar R Pattabiraman
Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression. bioRxiv : the preprint server for biology (2023)
Min Kyung Lee, Meredith S Brown, Owen M Wilkins, Diwakar R Pattabiraman, Brock C Christensen
Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions. Epigenomics 14 (9) (2022)
Meredith S Brown, Kristen E Muller, Diwakar R Pattabiraman
Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside. Cancers 14 (5) (2022)
Meredith S Brown, Behnaz Abdollahi, Owen M Wilkins, Hanxu Lu, Priyanka Chakraborty, Nevena B Ognjenovic, Kristen E Muller, Mohit Kumar Jolly, Brock C Christensen, Saeed Hassanpour, Diwakar R Pattabiraman
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer. Science advances 8 (31) (2022)